Risk of thrombocytopenia with Platelet‐derived Growth Factor Receptor Kinase Inhibitors (PDGFR‐TKIs) in cancer patients: A systematic review and meta‐analysis of phase II/III randomized controlled trials
2018 ◽
Vol 30
(6-8)
◽
pp. 323-331
◽
2019 ◽
Vol 134
◽
pp. 31-38
◽